Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
chazzledazzle's Profile
Displaying 1-50 of 2211 result(s).
CYDY CytoDyn Inc
10/20/2025 5:31:24 PM
Wear a black collared shirt, sport (7)
CYDY CytoDyn Inc
10/17/2025 9:51:43 PM
Lenacapavir
CYDY CytoDyn Inc
10/15/2025 9:38:04 PM
What makes you believe that all nec (3)
CYDY CytoDyn Inc
10/15/2025 9:14:44 PM
Thanks N2In, “ This is a good poi (2)
CYDY CytoDyn Inc
10/15/2025 9:03:55 PM
“ Anyway Dr Jay must try” I’m (13)
CYDY CytoDyn Inc
10/15/2025 6:15:51 PM
You should work for the FDA trial d (2)
CYDY CytoDyn Inc
10/15/2025 6:08:32 PM
Hopefully the “signal” will be (5)
CYDY CytoDyn Inc
10/15/2025 5:44:18 PM
“He suggested posting yesterday
CYDY CytoDyn Inc
10/14/2025 9:42:16 PM
It was pretty interesting at the en (3)
CYDY CytoDyn Inc
10/14/2025 9:07:36 PM
When it asks you to get app, just s (1)
CYDY CytoDyn Inc
10/14/2025 9:06:04 PM
Here’s an audio link. https://sou (3)
CYDY CytoDyn Inc
10/10/2025 4:29:36 PM
One amendment to my out last night. (2)
CYDY CytoDyn Inc
10/09/2025 5:22:00 PM
“Do we have anyone else in the bu (10)
CYDY CytoDyn Inc
10/09/2025 8:33:23 AM
https://www.cytodyn.com/newsroom/p (5)
CYDY CytoDyn Inc
10/08/2025 9:30:17 PM
“Merck would reasonably want at l
CYDY CytoDyn Inc
10/02/2025 10:13:06 PM
“…the company is trying to esta (3)
CYDY CytoDyn Inc
10/02/2025 10:07:09 PM
“ In parallel, we will be submitt (4)
CYDY CytoDyn Inc
10/02/2025 5:33:12 PM
It’s important to remember that a (1)
CYDY CytoDyn Inc
10/01/2025 10:29:44 PM
Is it a reasonable assumption on my
CYDY CytoDyn Inc
10/01/2025 5:50:51 PM
Syneos is our CRO also. (2)
CYDY CytoDyn Inc
10/01/2025 5:49:15 PM
"The phase 2, open-label, multicent (6)
CYDY CytoDyn Inc
10/01/2025 5:35:24 PM
I MASH for instance, the 525mg dose (1)
CYDY CytoDyn Inc
10/01/2025 5:21:40 PM
"... but 350 mg dose is inadequate (5)
CYDY CytoDyn Inc
10/01/2025 12:54:22 AM
Basket trial was 2021. This should (5)
CYDY CytoDyn Inc
10/01/2025 12:30:03 AM
The basket trial back in the day wa
CYDY CytoDyn Inc
09/30/2025 10:59:04 PM
Before I re-underline the Science S (18)
CYDY CytoDyn Inc
09/30/2025 5:53:56 PM
Opens a nice window for PD-L1 regul (1)
CYDY CytoDyn Inc
09/30/2025 5:51:38 PM
“I am guessing it also means that (7)
CYDY CytoDyn Inc
09/30/2025 5:44:38 PM
Probably not done often by pre-reve (3)
CYDY CytoDyn Inc
09/30/2025 5:40:15 PM
Nice work. Thanks. (1)
CYDY CytoDyn Inc
09/30/2025 5:31:26 PM
It’s significantly impt that the (3)
CYDY CytoDyn Inc
09/28/2025 4:35:40 PM
I'm entering this bitch session and (16)
CYDY CytoDyn Inc
09/28/2025 4:25:56 PM
Not trial design. Trial design appr (1)
CYDY CytoDyn Inc
09/20/2025 4:48:57 PM
Question: will new shares automatic (1)
CYDY CytoDyn Inc
09/19/2025 8:22:53 PM
Re: Charlie Sheen and Nader appeari (3)
CYDY CytoDyn Inc
09/19/2025 7:49:00 PM
Amen. People, stop helping so much.
CYDY CytoDyn Inc
09/16/2025 6:57:52 PM
“ AACR SPECIAL CONFERENCE IN CANC (4)
CYDY CytoDyn Inc
09/16/2025 6:55:35 PM
Exactly correct. Moving on up. Abou (3)
CYDY CytoDyn Inc
09/15/2025 6:49:50 PM
Reminds me of… “ Human Papillom (2)
CYDY CytoDyn Inc
09/14/2025 10:22:40 PM
From link : Monday 10/13 at 11a : 1 (3)
CYDY CytoDyn Inc
09/10/2025 10:08:54 PM
Thanks also Enjay for transcript. H (15)
CYDY CytoDyn Inc
09/10/2025 8:21:24 AM
Yes of course Craig. THAT would be
CYDY CytoDyn Inc
09/09/2025 8:19:54 PM
“…today announced a change of t
CYDY CytoDyn Inc
09/04/2025 4:44:36 PM
I wonder how RFK Jr feels about Dr. (2)
CYDY CytoDyn Inc
09/02/2025 9:30:34 PM
Weekly doses at 700mg is pretty exc (7)
CYDY CytoDyn Inc
08/29/2025 9:39:30 AM
I do. They had a guy on many of out (2)
CYDY CytoDyn Inc
08/28/2025 10:10:43 AM
Correct, they are throwing shade. A (9)
CYDY CytoDyn Inc
07/17/2025 11:55:52 PM
Mr Feuerstein gets sued on average (2)
CYDY CytoDyn Inc
07/16/2025 5:05:43 PM
Clearing the HIV viral reservoir is (3)
CYDY CytoDyn Inc
07/13/2025 4:18:05 PM
“ The one problem with this will (4)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Halia Therapeutics Gains FDA Orphan Drug Designation for MDS
  • Karat Packaging Announces Q3 Earnings Call for 2025
  • Nuvia Dental Implant Center Brings Innovative Care to Virginia
  • Crinetics Pharmaceuticals Advances Neuroendocrine Tumor Research
  • PHOMI Wraps Up Success at Global Trade Shows with eDisplay
  • GrowGeneration Corp Set to Release Q3 2025 Financial Results
  • Vote for Workhorse's Strategic Merger with Motiv Today
  • Quantum Leap Energy's Bold Steps in Nuclear Waste Solutions
  • Tree Island Steel Prepares for Financial Results Release
  • Apyx Medical Corporation Plans Q3 Fiscal Insights Call
  • SAP NS2 Secures Major $1B Army Contract for Cloud Solutions
  • Phathom Pharmaceuticals Set to Showcase VOQUEZNA at ACG 2025
  • BioAtla's Innovative Approach to OPSCC Treatment with Oz-V
  • Legal Dispute Erupts Over Meme Coins Featuring Melania Trump
  • Pre-Market Stock Movements: Major Declines in Key Companies
  • Discover Enchanting Towns for Year-Round Halloween Fun
  • Pacira BioSciences Showcases Real-World Studies at AMCP Nexus
  • Canada's Missing Middle Housing Report: Key Insights Revealed
  • Phathom Pharmaceuticals Showcases Innovative VOQUEZNA at ACG Meeting
  • Wi-Fi Equipment Market Gaining Momentum Amid Tariff Concerns
  • Teads Introduces CTV Performance for Enhanced Advertising Success
  • Ramaco Initiates Construction of New Rare Earth Processing Facility
  • Unveiling the Power of Ozuriftamab Vedotin in Advanced OPSCC
  • iDEAL Semiconductor's SuperQ Technology Gains Automotive Qualification
  • High Tide Expands Canna Cabana Presence with New Store
  • Join Nilorn's Q3 Presentation and Discover Innovative Solutions
  • Ebix Unveils Cutting-Edge ExposureHub for Enhanced Risk Management
  • StepStone Group Expands Its Global Reach with New Office
  • Collegium Pharmaceutical's Upcoming Q3 2025 Financial Preview
  • SCIENTURE Launches Arbli™ Oral Suspension for Hypertension
  • Empowering Team Members: Taco Bell's Commitment to Growth
  • Smart Bridge Technologies Set to Transform Crypto-Finance Integration
  • Integer Holdings Corporation Reports Impressive Q3 2025 Growth
  • Innovative Sepsis Diagnostics: A Study on SeptiCyte RAPID
  • electroCore Set to Reveal Financial Insights on Q3 Results
  • Innovative Portable Technology Enhances Wastewater Surveillance
  • EPAM Introduces AI/Run™.Transform to Enhance AI Adoption
  • Amaero's Growth Trajectory and Future Prospects Explored
  • Diwali at Times Square: A Celebration of Light and Unity
  • Beyond Air Prepares for Q2 2026 Financial Results Release
  • Cyber Scams Target Job Seekers: A Growing Concern
  • ContextLogic to Share Financial Insights and Future Plans
  • Allegis Global Solutions Celebrates Prestigious UiPath Honor
  • Revolutionary Steps in Weight Management: Discover Prolon® Today
  • STMicroelectronics Faces Challenges Amid Margin Pressures
  • Unlocking Dividend Potential: Earning $500 Monthly with Ford
  • ArisGlobal's Innovative MedDRA Coding Agent Revolutionizes Compliance
  • Unlocking Financial Success: Zafin and Curinos Revolutionize Deal Management
  • Amsted Automotive Achieves Prestigious Manufacturer Award
  • Avantor Partners with p-Chip to Ensure Smart Consumable Traceability
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site